Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in recurrent chronic rhinosinusitis with nasal polyposis
IRCT201211062106N4Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of itraconazole in chronic rhinosinusitis (CRS), chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinitis, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Clinical symptom improvement and Radiologic improvement. Started Nov 2011; status: completed.
02
Drugs
itraconazole
03
Conditions
chronic rhinosinusitis (CRS)chronic rhinosinusitis with nasal polyps (CRSwNP)chronic rhinitis
Beyond the preview
Go deeper on IRCT201211062106N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201211062106N4.